C-Peptide vs CCP: Two Peptides, One Acronym

C-peptide and CCP are unrelated materials that collide only in abbreviation. C-peptide is the 31-residue connecting peptide excised from proinsulin during insulin maturation — one defined sequence, monoisotopic MW near 3020.3 Da, linear, no disulfides. CCP means cyclic citrullinated peptide: not a single molecule but a family of synthetic antigens, typically 12–25 residues, carrying one or more citrulline residues and closed into a ring, used as capture antigen in autoantibody assay development. Different sequences, different synthesis chemistry, different failure modes on the certificate of analysis. A catalog line that reads "CCP peptide" with no printed sequence is not a specifiable purchase. A catalog line that reads "C-peptide" is — but its analytical characterization is harder than the price tag suggests. Below is what separates them on paper and on the instrument.

The two molecules, side by side

C-peptide, human sequence: EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ. Count what is in it and what is not:

5 acidic residues (three Glu near the N-terminus, one Asp, two more Glu downstream) and zero basic residues — no Lys, no Arg, no His. Calculated pI sits around 3.2.
Zero aromatic residues. No Trp, no Tyr, no Phe. The molar extinction coefficient at 280 nm is effectively 0.
Four Gln residues and a glycine-rich midsection (GGGPGAG).
No Cys, so no disulfide bond and no free-thiol question at all.

A CCP-type antigen inverts nearly every one of those properties. Citrulline is a neutral, deiminated arginine; the peptides are usually cyclized head-to-tail or through a disulfide bridge between two engineered Cys residues, and they are generally designed with aromatic and basic residues intact for antibody recognition. The commercial second- and third-generation CCP antigens used in diagnostic kits are proprietary sequences — they are not available as catalog items from any research-use supplier, a point covered further below.

Why C-peptide is awkward to analyze — and what that means for a COA

Zero absorbance at 280 nm has consequences that show up directly on the paperwork.

UV purity must be measured at 210–220 nm (peptide-bond absorbance), typically 214 nm. Any COA reporting C-peptide purity "by HPLC at 280 nm" is either a template error or a fabricated document. Ask which.
Absolute quantitation by A280 is impossible. Concentration has to come from quantitative amino acid analysis, elemental nitrogen determination, or a validated qNMR method. Expect $150–$350 per sample and 5–10 business days for outsourced AAA.
Positive-mode ESI response is poor. With no basic residue to hold a proton, the peptide ionizes weakly and spreads across low charge states. Labs running LC-MS/MS on C-peptide routinely fight signal, and negative-mode or derivatization approaches get used instead. Intact-mass confirmation still works — a ±5 ppm match on a high-resolution instrument at 60,000 resolving power is a reasonable acceptance criterion — but sensitivity is not comparable to a basic-residue-rich peptide of the same length.
Four Gln residues mean deamidation is the primary degradation pathway, each event adding +0.984 Da. A batch stored badly reads as a cluster of +1 Da satellites on the deconvoluted spectrum.

That last number is where the two materials quietly meet.

The +0.984 Da problem shared by both

Arginine → citrulline is a net substitution of NH by O: +0.98402 Da. Asparagine or glutamine deamidation is a net substitution of NH by O: +0.98401 Da. The elemental change is identical, so no mass spectrometer resolves them by accurate mass — not at 5 ppm, not at 0.5 ppm, not ever. This is the single most common characterization error on citrullinated peptide material, and it is also why a poorly stored C-peptide lot can be mistaken for something else entirely.

The workarounds are specific and worth demanding from a supplier:

Neutral loss of isocyanic acid, 43.0058 Da, from citrulline under CID/HCD fragmentation. It is diagnostic; deamidated Asn/Gln does not produce it.
Site localization by MS/MS, confirming the +0.984 sits on the position the sequence specifies rather than on a nearby Gln.
Chemical derivatization of the ureido group (2,3-butanedione or antipyrine chemistries) as orthogonal confirmation.
Retention-time comparison against the arginine-containing parent sequence, which usually elutes measurably earlier on a C18 gradient.

A certificate that reports only "MS confirms expected mass" on a citrullinated peptide has confirmed almost nothing. The expected mass and the most likely degradation artifact are the same number.

Why "CCP" is a specification problem, not a product

For the cyclic material, the disulfide is the second checkpoint. Ring closure removes 2.016 Da, and incomplete oxidation leaves linear peptide with free thiols that co-elute close to the cyclic form. Quantifying it is inexpensive and non-negotiable:

Ellman's assay (DTNB), absorbance at 412 nm, ε ≈ 14,150 M⁻¹cm⁻¹, with a specification of <5% free thiol.
Analytical RP-HPLC showing baseline separation of linear and cyclic species, not a single peak integrated at 98% with no discussion of what the shoulder is.
Confirmation of intramolecular versus intermolecular closure — dimers and oligomers formed by cross-linking between molecules carry the same per-residue mass deficit and are only caught by looking at the intact charge envelope or by SEC.

Citrulline building blocks also drive cost. Fmoc-Cit-OH runs meaningfully more expensive per gram than Fmoc-Arg(Pbf)-OH, and multi-citrulline sequences compound it. Custom synthesis of a 15–25-residue cyclic peptide with 2–3 citrullines at >95% purity, 10–25 mg scale, lands roughly in the $600–$2,500 range depending on difficulty and turnaround, typically 4–7 weeks. A 31-mer linear peptide at comparable scale and purity generally sits between $800 and $2,500.

Reading the certificate of analysis: purity is not content

The most reliable way to overpay is to conflate HPLC area purity with net peptide content.

A lyophilized TFA-salt peptide at 98.5% HPLC purity commonly assays at 70–85% net peptide content by AAA, with the balance being TFA counterions, residual water, and inorganic salts. Acidic peptides like C-peptide bind fewer TFA counterions than basic sequences, so content can run higher — but "higher" is a hypothesis until measured, not an assumption to build a curve on.

Practical arithmetic: a 1 mg vial priced at $300 that assays at 75% content costs $400 per milligram of actual peptide. A $380 vial at 92% content costs $413/mg — nearly identical, despite a 27% difference in headline price. Purchasing decisions made on sticker price alone are frequently wrong by a margin larger than the discount being chased. See quality for how batch documentation is structured here, and wholesale for volume-tier structure.

Storage, stability, and the shelf life actually available

Lyophilized powder at -20 °C, desiccated and protected from light: typical retest interval 24–36 months. At -80 °C, longer, though few suppliers will certify past 36 months without stability data to back the claim.
Ambient shipping of lyophilized material is acceptable for short transit; cold-chain is a documentation preference, not a chemical necessity, for a dry acidic peptide. Details on transit handling are on shipping.
Freeze-thaw is the dominant avoidable loss. Repeated cycling on a solubilized aliquot degrades faster than months of proper dry storage. Aliquoting at first opening is the standard control.
Deamidation accelerates above pH 7. For a four-Gln peptide, storage in neutral or basic buffer is the fastest route to a heterogeneous, useless lot.
Cyclic citrullinated material is additionally sensitive to thiol-disulfide exchange in reducing environments; residual DTT or TCEP contamination will reopen the ring.

When neither material is worth buying

This is the section that costs sales, and it should.

Do not buy a research-grade C-peptide if the work requires a traceable calibrator. A catalog peptide with an area-percent COA is not a certified reference material. It carries no certified assigned value, no uncertainty budget, and no metrological traceability chain. Work that needs to be defensible against an external standard requires a CRM or an international standard, which costs several multiples more and comes with a certificate stating an assigned value ± expanded uncertainty. Substituting a research peptide there produces numbers that cannot be compared to anyone else's.

Do not buy "CCP" expecting the diagnostic antigen. The CCP2 and CCP3 antigen sequences used in commercial immunoassays are proprietary and not sold as reference materials. Purchasing a generically labeled cyclic citrullinated peptide and expecting assay-equivalent behavior is a design error that will not surface until well into method development, after the money is spent.

Do not buy either if there is no in-house means to verify. A COA that cannot be independently checked adds paperwork, not confidence. A lab without access to analytical HPLC and MS — or a budget for third-party confirmation at roughly $200–$600 per sample — is buying a document.

Do not buy 25 mg to use 2 mg. A peptide consumed at 0.5 mg per quarter across an 8-quarter project needs 4 mg, not a bulk vial that will pass its retest date first. Bulk pricing that looks like a 40% per-milligram saving is a 100% loss on the fraction that expires unused.

Do not buy from a research-use supplier if the work requires GMP. Nothing here carries GMP status, and no COA revision will change that. Scope is stated plainly on research use only and disclaimer.

Do not buy a citrullinated peptide from a supplier who will not commit to citrulline site confirmation. The entire analytical value of the material rests on that one localization. Without it, the purchase is a 20-mer of unverified composition.

Qualifying a supplier for either material

Concrete, answerable questions — a supplier who cannot answer within one business day is answering.

The full one-letter sequence, including modification positions and cyclization chemistry, printed on the COA rather than described in prose.
Lot-specific chromatograms and spectra, not a representative example from an earlier batch. Confirm the lot number on the trace matches the vial.
Detection wavelength, column, gradient, and injection volume used for the reported purity figure. A 98% purity at 214 nm on a 30-minute gradient is a different claim than 98% on a 10-minute gradient.
Net peptide content and counterion identity, stated as measured values with the method named.
The retest date and the stability data supporting it, not just a date.
Whether the same lot can be re-supplied, and for how long — mid-project lot changes force re-qualification.

Comparative notes on how different suppliers document these points are collected in the library, and specification questions on a particular lot go through contact.

The short version: C-peptide is one sequence with an unusual analytical profile — invisible at 280 nm, poorly ionizing, deamidation-prone. CCP is a category, not a compound, whose defining modification is mass-indistinguishable from the most common degradation artifact in peptide chemistry. Neither is difficult to buy. Both are easy to buy badly.

Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.